Saptalis Pharmaceuticals' Unattributed Round

Saptalis Pharmaceuticals raised a round of funding on September 11, 2015.

Saptalis Pharmaceuticals is a specialty generic pharmaceutical company creating value through R&D, aggressively building a product development pipeline and secure FDA marketing approvals for multiple …

Articles about Saptalis Pharmaceuticals' Unattributed Round: